sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
2-Sep-2014 05:18
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 26-50 out of 892.

<< < 1 | 2 | 3 | 4 | 5 | 6 > >>

Public Release: 21-Aug-2014
PLOS ONE
A novel 'man and machine' decision support system makes malaria diagnostics more effective
A Finnish-Swedish research group has developed a novel 'man and machine' decision support system for diagnosing malaria infection. The method is based on computer vision algorithms combined with visualization of the relevant sample areas to human observers on a tablet computer. The system has a huge potential to increase the throughput in malaria diagnostics. Several other medical applications are in the development stage.

Contact: Dr. Nina Linder
nina.linder@helsinki.fi
358-445-555-407
University of Helsinki

Public Release: 20-Aug-2014
New England Journal of Medicine
NEJM Perspective: 'Studying 'Secret Serums' -- Toward Safe, Effective Ebola Treatments'
Conducting clinical studies of agents to treat Ebola and allowing compassionate use of those agents are not necessarily mutually exclusive, writes Georgetown University Medical Center's Jesse L. Goodman, M.D., M.P.H., in a perspective piece published Wednesday in the New England Journal of Medicine.

Contact: Karen Tever
km463@georgetown.edu
215-514-9751
Georgetown University Medical Center

Public Release: 20-Aug-2014
Nature
New research shows seals and sea lions likely spread tuberculosis to humans
Scientists who study tuberculosis have long debated its origins. New research shows that tuberculosis likely spread from humans in Africa to seals and sea lions that brought the disease to South America and transmitted it to Native people there before Europeans landed on the continent.
National Science Foundation, European Research Council, Smithsonian Institution, Swiss National Science Foundation, National Institutes of Health, Wenner-Gren Foundation, Wellcome Trust

Contact: Julie Newberg
480-727-3116
Arizona State University

Public Release: 19-Aug-2014
Infection and Immunity
New vaccine shows promise as stronger weapon against both tuberculosis and leprosy
A new University of California Los Angeles-led study finds that a recombinant variant of the century-old vaccine Bacille Calmette-Guerin is superior to Bacille Calmette-Guerin in protecting against tuberculosis in animal models, and also cross protects against leprosy. In addition, the researchers found that boosting that variant, called rBCG30, with a particular protein found in both tuberculosis and leprosy provides considerably stronger protection against leprosy.
National Institutes of Health, National Hansen's Disease Programs, University of California Los Angeles Jonsson Comprehensive Cancer Center, Center for AIDS Research

Contact: Enrique Rivero
erivero@mednet.ucla.edu
310-794-2273
University of California - Los Angeles Health Sciences

Public Release: 19-Aug-2014
Water Resources Research
This week from AGU: Long-term ecological research, predicting cholera outbreaks
This week from the American Geophysical Union: Long-term ecological research, predicting cholera outbreaks

Contact: Alexandra Branscombe
abranscombe@agu.org
202-777-7516
American Geophysical Union

Public Release: 19-Aug-2014
Biophysical Journal
Laser optical tweezers reveal how malaria parasites infect red blood cells
Little is known about how malaria invades one red blood cell after another because it happens so quickly. In a new study, researchers used laser optical tweezers to study interactions between the disease-causing parasite and red blood cells. The findings reveal surprising new insights into malaria biology and pave the way for the development of more effective drugs or vaccines for a disease that affects hundreds of millions of people around the world.

Contact: Mary Beth O'Leary
moleary@cell.com
617-397-2802
Cell Press

Public Release: 18-Aug-2014
Clinical Microbiology and Infection
Invasion of the Americas by mosquito-borne virus likely
While media attention has been focused recently on coronavirus cases in the Arabian peninsula and the Ebola outbreak in West Africa, experts note that another threat lies in the spread of Chikungunya fever, an illness that is transmitted by mosquitoes and can cause fever, joint and muscle pain, headaches, and rashes. While it does not often cause death, the symptoms can be severe and disabling, with no treatment available.

Contact: Nicole Weingartner
sciencenewsroom@wiley.com
201-748-5808
Wiley

Public Release: 18-Aug-2014
Journal of Animal Ecology
Ebola has profound effects on wildlife population dynamics
New research in gorillas that were affected by an Ebola virus outbreak shows that disease can influence reproductive potential, immigration and social dynamics, and it highlights the need to develop complex models that integrate all the different impacts of a disease.

Contact: Nicole Weingartner
sciencenewsroom@wiley.com
201-748-5808
Wiley

Public Release: 18-Aug-2014
Annals of Internal Medicine
Doctors worldwide should stay current on developments in ongoing Ebola epidemic
Doctors in hospitals and emergency rooms around the world should be prepared to recognize Ebola virus infection and isolate patients if necessary, infectious disease specialists recommend. However, concerns that Ebola will spread beyond West Africa to Europe and North America are unfounded because of the way Ebola is transmitted and because of highly developed hospital infection control practices.

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory Health Sciences

Public Release: 15-Aug-2014
UTMB named a World Health Organization Collaborating Center for Vaccine Research
The world experts on vaccine development at the University of Texas Medical Branch at Galveston have received an international designation acknowledging their unique niche in a sphere where research, government regulation and big pharma often collide.

Contact: Molly Dannenmaier
mjdannen@utmb.edu
409-772-8790
University of Texas Medical Branch at Galveston

Public Release: 14-Aug-2014
Annals of Global Health
Global public health objectives need to address substance abuse in developing countries
Substance addiction is a large and growing problem for developing societies. A new study that surveyed reports on modalities for treating addiction and their effectiveness in the developing world calls on policymakers to use this information to support the design of programs that meet known population needs. The study also encourages looking at ways to adapt the Alcoholics Anonymous model to fit different cultural norms. The findings are published in the Annals of Global Health.

Contact: Eileen Leahy
e.leahy@elsevier.com
732-238-3628
Elsevier Health Sciences

Public Release: 14-Aug-2014
JAIDS: Journal of Acquired Immune Deficiency Syndromes
Scientists detail urgent research agenda to address chronic disease toll
According to recommendations resulting from a multidisciplinary conference sponsored by the National Institutes of Health, scientists and physicians in low- and middle-income countries should build on existing HIV research to study and treat chronic conditions.

Contact: Jeff Gray
Jeffrey.Gray@nih.gov
301-496-2075
NIH/Fogarty International Center

Public Release: 13-Aug-2014
New England Journal of Medicine
Ebola outbreak highlights global disparities in health-care resources
The outbreak of Ebola virus disease that has claimed more than 1,000 lives in West Africa this year poses a serious, ongoing threat to that region: the spread to capital cities and Nigeria -- Africa's most populous nation -- presents new challenges for healthcare professionals. The situation has garnered significant attention and fear around the world, but proven public health measures and sharpened clinical vigilance will contain the epidemic and thwart a global spread.
NIH/National Institute of Allergy and Infectious Diseases

Contact: NIAID Office of Communications
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 13-Aug-2014
Cell Host & Microbe
New insights into the survival and transmission strategy of malaria parasites
Malaria parasites exploit the function of the epigenetic regulator HP1 to promote survival and transmission between human hosts, a new study shows. Using HP1 the parasite controls expression of surface antigens to escape immune responses in the infected victim. This prolongs survival of the parasite in the human blood stream and secures its transmission via mosquitoes. The study paves important avenues for new intervention strategies to prevent severe disease and malaria transmission.
Swiss National Science Foundation, Singaporean National Medical Research Council, OPO Foundation, Rudolf Geigy Foundation, Boehringer Ingelheim Fonds

Contact: Christian Heuss
christian.heuss@unibas.ch
41-612-848-683
Swiss Tropical and Public Health Institute

Public Release: 13-Aug-2014
JAIDS: Journal of Acquired Immune Deficiency Syndromes
With advances in HIV care, survivors face other disease risks
As effective treatments for HIV become more widely available in low-income and middle-income countries, there's an urgent need to assess and manage health risks in the growing number of people living with HIV. An update on non-communicable diseases among HIV-positive populations in low-income and middle-income countries appears as a supplement to in JAIDS: Journal of Acquired Immune Deficiency Syndromes. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Contact: Connie Hughes
Connie.Hughes@wolterskluwer.com
646-674-6348
Wolters Kluwer Health

Public Release: 13-Aug-2014
Cell Host & Microbe
Ebola protein blocks early step in body's counterattack on virus
The newly published study explains for the first time how the production by the virus of a protein called Ebola Viral Protein 24 stops the interferon-based signals from ramping up immune defenses.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Greg Williams
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine

Public Release: 13-Aug-2014
Emerging Microbes & Infections
Researchers uncover clues about how the most important TB drug attacks its target
Researchers at the Johns Hopkins Bloomberg School of Public Health say they have discovered a new clue to understanding how the most important medication for tuberculosis (TB) works to attack dormant TB bacteria in order to shorten treatment.
NIH/National Institute of Allergy and Infectious Diseases, Major Project of the Twelfth Five-Year Plan, National Natural Science Foundation of China

Contact: Stephanie Desmon
sdesmon1@jhu.edu
410-955-7619
Johns Hopkins University Bloomberg School of Public Health

Public Release: 13-Aug-2014
Cell Host & Microbe
Researchers uncover how Ebola virus disables immune response
The Ebola outbreak in West Africa has brought a lot of attention to the deadly virus. According to the World Health Organization, up to 90 percent of those infected with Ebola die from the virus. Now, researchers publishing Aug. 13 in the journal Cell Host & Microbe reveal how Ebola blocks and disables the body's natural immune response. Understanding how Ebola disarms immune defenses will be crucial in the development of new treatments for the disease.

Contact: Mary Beth O'Leary
moleary@cell.com
617-397-2802
Cell Press

Public Release: 13-Aug-2014
New England Journal of Medicine
Estimated 1.65 million global cardiovascular deaths each year linked to high sodium consumption
More than 1.6 million cardiovascular-related deaths per year can be attributed to sodium consumption above the World Health Organization's recommendation of 2.0 grams per day, researchers have found in a new analysis of populations across 187 countries, to be published in the Aug. 14 issue of the New England Journal of Medicine.
Bill and Melinda Gates Foundation

Contact: Jennifer Kritz
jennifer.kritz@tufts.edu
617-636-3707
Tufts University, Health Sciences Campus

Public Release: 13-Aug-2014
Cell Host & Microbe
Gut flora influences HIV immune response
Normal microorganisms in the intestines appear to play a pivotal role in how the HIV virus foils a successful attack from the body's immune system, according to new research from Duke Medicine.
NIH/National Institute of Allergy and Infectious Diseases, NIH/National Cancer Institute

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center

Public Release: 12-Aug-2014
Journal of Epidemiology and Community Health
Immigrants at lower risk of overdose, death from codeine than people born in Canada
Immigrants are at lower risk of an overdose or death after being prescribed codeine than people born in Canada, a new study has found.
Canadian Drug Safety and Effectiveness Research Network, Institute for Clinical Evaluative Sciences

Contact: Leslie Shepherd
shepherdl@smh.ca
416-864-6094
St. Michael's Hospital

Public Release: 12-Aug-2014
NIH awards $20 million grant to Oak Crest Institute of Science
Researchers at the Oak Crest Institute of Science have been awarded a $20 million grant from the National Institutes of Health to systematically develop an intravaginal ring capable of delivering powerful antiretroviral drugs to prevent the spread of sexually transmitted HIV in women. This Program will allow researchers, for the first time, to rigorously test a large group of antiretroviral drugs in a systematic fashion so that they can determine the best-performing candidates in order to advance them rapidly into clinical trials.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Marc Baum
info@oak-crest.org
626-817-0883
Oak Crest Institute of Science

Public Release: 12-Aug-2014
Protecting newborns: Milk protein could save millions from harm
An international effort led by the University of Sydney hopes to protect hundreds of Bangladeshi newborns from a host of severe health problems by assessing the effect of lactoferrin, a natural protein found in breast and cow's milk, in the treatment of iron deficiency anemia in pregnancy.
Bill and Melinda Gates Foundation, US Agency for International Development, Norwegian Government, Grand Challenges Canada, UK Agency for International Development

Contact: Dan Gaffney
daniel.gaffney@sydney.edu.au
61-411-156-015
University of Sydney

Public Release: 12-Aug-2014
XIII International Congress on Parasitology
New drug candidate for Chagas disease tested in patients in Bolivia
The Drugs for Neglected Diseases initiative announced today at the International Congress of Parasitology, the launch of a Phase II drug trial to test fexinidazole, a drug shelved in the 1980s and 'rediscovered' by DNDi nearly a decade ago, for Chagas disease patients. The drug is also being tested in patients in Africa for two other parasitic diseases, sleeping sickness and visceral leishmaniasis.
Drugs for Neglected Diseases initiative

Contact: Betina Moura
bmoura@dndi.org
55-219-812-22798
Drugs for Neglected Diseases Initiative

Public Release: 12-Aug-2014
PLOS Medicine
Heart failure is a substantial health burden in low- and middle-income countries
Heart failure is a major public health burden in many low- and middle-income countries, with substantial variation in the presentation, causes, management, and outcomes of heart failure across different LMICs, according to a study published in this week's PLOS Medicine. The study, led by Kazem Rahimi and colleagues from the George Institute for Global Health, also finds that a large proportion of patients are not receiving pharmacological treatments for heart failure.
National Institute for Health Research, Oxford Biomedical Research Centre Programme, National Institute for Health Research Career Development Fellowship

Contact: Maya Sandler
medicinepress@plos.org
PLOS

Showing releases 26-50 out of 892.

<< < 1 | 2 | 3 | 4 | 5 | 6 > >>